Kynurenine pathway in depression
Part of Mental health clinical trials.
This study looks at a chemical pathway in the body that may be linked to depression. If you have depression and have not taken medication for at least 4 months, this study could help understand your condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with major depressive disorder.
- You have not taken any depression medication for at least 4 months.
- You do not have other psychiatric conditions like anxiety or substance use disorder.
- You do not have any chronic medical illness that affects your immune system.
- You are not currently on immune-modulating therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This study collects health data and samples from people with major depression and healthy volunteers to learn more about the condition. It may help improve future treatments.
This study looks at how the bacteria in your gut might affect your mood and mental health. You'll provide samples and answer questions, and you may get a discounted testing kit to learn about your own gut health.
This study tests an investigational drug called KH607 for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms over time. Participants must stop other depression medications before starting and will be monitored closely.
This study tests different medication combinations in adults with major depressive disorder who are also having suicidal thoughts. It aims to find a more effective and safer treatment approach for this serious condition.
This study looks at a substance called kynurenine in the blood of pregnant women who have chronic kidney disease (CKD) compared to those who don't. It aims to understand how kidney function affects this substance during pregnancy, which may help improve care for women with kidney issues.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.